Karamfilova, V. (2022) “Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease”, Turkish Journal of Gastroenterology, 33(3), pp. 233–239. doi: 10.5152/tjg.2021.201165.